Large Volume Parenteral (LVP) Global Market Report 2024

Description

Large Volume Parenteral (LVP) pertains to sterile intravenous solutions with a volume of 100 ml or more, undergoing terminal sterilization through heat. These solutions play a crucial role in intravenous infusions, facilitating the administration of hydration, nourishment, and medications.

The primary types of Large Volume Parenteral (LVP) include soft bag LVP, plastic bag LVP, and glass bottle LVP. Soft bag LVP involves the use of flexible bags containing sterilized intravenous solutions, employed in medical settings to deliver fluids and medications to patients. The varying volumes, ranging from 100 ml to 2000 ml and beyond, cater to different infusion needs, such as basic infusion, therapeutic infusion, and nutritious infusion. End-users of LVP include hospitals, medical centers, and other healthcare facilities.

The large volume parenteral (LVP) market research report is one of a series of new reports from The Business Research Company that provides large volume parenteral (LVP) market statistics, including large volume parenteral (LVP) industry global market size, regional shares, competitors with a large volume parenteral (LVP) market share, detailed large volume parenteral (LVP) market segments, market trends and opportunities, and any further data you may need to thrive in the large volume parenteral (LVP) industry. This large volume parenteral (LVP) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The large volume parenteral (lvp) market size has grown strongly in recent years. It will grow from $11.42 billion in 2023 to $12.44 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth observed in the historic period can be ascribed to several factors, including the escalating prevalence of chronic diseases, a notable increase in the aging population, a growing demand for sterile pharmaceuticals, the expansion of healthcare infrastructure, and the establishment of regulatory frameworks for the pharmaceutical sector.

The large volume parenteral (lvp) market size is expected to see strong growth in the next few years. It will grow to $17.35 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The anticipated growth in the forecast period can be credited to the increasing demand for biologics and biosimilars, a rise in healthcare expenditure, the expansion of pharmaceutical outsourcing, a heightened focus on personalized medicine, and the globalization of pharmaceutical supply chains. Key trends expected in the forecast period encompass technological advancements in manufacturing processes, the integration of advanced technologies in pharmaceutical production, the adoption of single-use technologies, the development of high-concentration formulations, and the increasing application of 3D printing in pharmaceuticals.

The projected growth in the large-volume parenteral market is expected to be fueled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting three months or longer and having the potential to worsen over time, are on the rise, driven primarily by factors such as tobacco use, exposure to smoke, and poor nutrition. Patients with chronic diseases often require a balanced ratio of essential nutrients to support strength maintenance. The parenteral mode of administration is advantageous in delivering precise pharmaceutical dosages, as it allows for direct absorption into the circulation, bypassing the digestive system. For example, in January 2023, the National Center for Biotechnology Information (NCBI) projected a 99.5% increase in individuals aged 50 years and older with at least one chronic illness in the US by 2050, rising from 71.522 million in 2020 to 142.66 million. Consequently, the growing prevalence of chronic diseases is a key driver for the expansion of the large-volume parenteral market.

The anticipated growth in the large-volume parenteral market is further driven by increasing healthcare expenditure. Healthcare expenditure, reflecting the rising financial investment in healthcare services and related activities, is often linked to the development and expansion of healthcare infrastructure. This includes the establishment of new hospitals, clinics, and healthcare facilities, enhancing the overall capacity to deliver medical services and contributing to the demand for Large Volume Parenteral (LVP) solutions. In May 2023, the Office for National Statistics reported that the UK spent a total of £280.7 billion on healthcare in 2021, amounting to £4,188 per person. Notably, healthcare spending increased by 9.4% in nominal terms and 9.7% in actual terms between 2020 and 2021. Government-financed healthcare expenditures accounted for 83.0% of all healthcare spending in 2021, reaching £233.1 billion with a real growth rate of 9.6%. Therefore, the escalating healthcare expenditure emerges as a significant factor driving the growth of the large-volume parenteral market.

Product innovation is a prominent and popular trend in the large-volume parenteral market, with major players dedicating efforts to the creation of innovative products to enhance their market positions. An illustrative example of this trend is observed with SGD Pharma SA, a France-based producer of molded and tubular glass for pharmaceutical primary packaging. In March 2022, SGD Pharma launched 100-ml type I molded glass vials that are sterile and ready for aseptic filling and finishing of parenteral medicinal formulations. These vials serve to prevent scratches, facilitate the visual examination of filled vials, and reduce the likelihood of rejection during quality control processes. This product innovation aligns with the market's focus on enhancing the quality and efficiency of large-volume parenteral products.

Major players in the market are strategically focusing on the development of innovative formulations to bolster their market position. The creation of innovative formulations plays a pivotal role in driving the success and growth of the large volume parenteral market. These formulations address clinical challenges, enhance patient outcomes, and adapt to the dynamic landscape of healthcare. For instance, in November 2022, WuXi AppTec, a leading pharmaceutical development and manufacturing company based in China, launched a Parenteral Formulation Manufacturing Line in Wuxi City. This new line features an integrated 15 m³ lyophilizer housed in a completely enclosed isolator, along with a fully automated vial loading and unloading system. The filling line accommodates vials for solutions and lyophilized powder in various sizes, enabling quick mode transitions and significantly accelerating large-volume parenteral drug product production speed at 200 vials per minute. The facility boasts an innovative filling machine and a state-of-the-art containment system, aligning with global cGMP requirements.

In March 2022, Fresenius Kabi, a healthcare company based in Germany, made a strategic move by acquiring Ivenix Inc. for $240 million. This acquisition aims to broaden Fresenius Kabi's access to infusion systems in hospitals, complementing its intravenous fluids and infusion treatment offerings, and reinforcing its position in the US market. Ivenix Inc., a US-based medical technology company, specializes in the development of the Ivenix Large Volume Pump (LVP). This strategic acquisition further strengthens Fresenius Kabi's capabilities in the large volume parenteral market.

Major companies operating in the large volume parenteral (lvp) market report are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Becton Dickinson and Company, Otsuka Holdings Co Ltd., Baxter International Inc., B Braun Melsungen AG, Grifols SA, Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Nelson Laboratories LLC, Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd, Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd, Pentagon Labs Ltd., DJ Labs Pvt Ltd., Higgs Healthcare.

North America was the largest region in the large volume parenteral (LVP) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the large volume parenteral (lvp) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The large-volume parenteral (LVP) market consists of sales of sterile intravenous solutions, peritoneal dialysis solutions, plasma substitutes, and sterile powders. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Large Volume Parenteral (LVP) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on large volume parenteral (lvp) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for large volume parenteral (lvp) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The large volume parenteral (lvp) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Soft Bag LVP; Plastic Bag LVP; Glass Bottle LVP
2) By Volume: 100 ML - 250 ML; 250 ML - 500 ML; 500 ML - 1000 ML; 1000 ML -2000 ML; 2000 And More
3) By Application: Basic Infusion; Therapeutics Infusion; Nutritious Infusion
4) By End-User: Hospital; Medical Centers; Other End Users
Companies Mentioned: Pfizer Inc.; Fresenius Kabi AG; Abbott Laboratories Inc.; Becton Dickinson and Company; Otsuka Holdings Co Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13718

1. Executive Summary

2. Large Volume Parenteral (LVP) Market Characteristics

3. Large Volume Parenteral (LVP) Market Trends And Strategies

4. Large Volume Parenteral (LVP) Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Large Volume Parenteral (LVP) Market Size and Growth

5.1. Global Large Volume Parenteral (LVP) Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Large Volume Parenteral (LVP) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Large Volume Parenteral (LVP) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Large Volume Parenteral (LVP) Market Segmentation

6.1. Global Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Soft Bag LVP
Plastic Bag LVP
Glass Bottle LVP
6.2. Global Large Volume Parenteral (LVP) Market, Segmentation By Volume, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

100 ML - 250 ML

250 ML - 500 ML

500 ML - 1000 ML

1000 ML -2000 ML

2000 And More

6.3. Global Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Basic Infusion
Therapeutics Infusion
Nutritious Infusion
6.4. Global Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital
Medical Centers
Other End Users

7. Large Volume Parenteral (LVP) Market Regional And Country Analysis

7.1. Global Large Volume Parenteral (LVP) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Large Volume Parenteral (LVP) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Large Volume Parenteral (LVP) Market

8.1. Asia-Pacific Large Volume Parenteral (LVP) Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Large Volume Parenteral (LVP) Market

9.1. China Large Volume Parenteral (LVP) Market Overview
9.2. China Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Large Volume Parenteral (LVP) Market

10.1. India Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Large Volume Parenteral (LVP) Market

11.1. Japan Large Volume Parenteral (LVP) Market Overview
11.2. Japan Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Large Volume Parenteral (LVP) Market

12.1. Australia Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Large Volume Parenteral (LVP) Market

13.1. Indonesia Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Large Volume Parenteral (LVP) Market

14.1. South Korea Large Volume Parenteral (LVP) Market Overview
14.2. South Korea Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Large Volume Parenteral (LVP) Market

15.1. Western Europe Large Volume Parenteral (LVP) Market Overview
15.2. Western Europe Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Large Volume Parenteral (LVP) Market

16.1. UK Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Large Volume Parenteral (LVP) Market

17.1. Germany Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Large Volume Parenteral (LVP) Market

18.1. France Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Large Volume Parenteral (LVP) Market

19.1. Italy Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Large Volume Parenteral (LVP) Market

20.1. Spain Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Large Volume Parenteral (LVP) Market

21.1. Eastern Europe Large Volume Parenteral (LVP) Market Overview
21.2. Eastern Europe Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Large Volume Parenteral (LVP) Market

22.1. Russia Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Large Volume Parenteral (LVP) Market

23.1. North America Large Volume Parenteral (LVP) Market Overview
23.2. North America Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Large Volume Parenteral (LVP) Market

24.1. USA Large Volume Parenteral (LVP) Market Overview
24.2. USA Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Large Volume Parenteral (LVP) Market

25.1. Canada Large Volume Parenteral (LVP) Market Overview
25.2. Canada Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Large Volume Parenteral (LVP) Market

26.1. South America Large Volume Parenteral (LVP) Market Overview
26.2. South America Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Large Volume Parenteral (LVP) Market

27.1. Brazil Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Large Volume Parenteral (LVP) Market

28.1. Middle East Large Volume Parenteral (LVP) Market Overview
28.2. Middle East Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Large Volume Parenteral (LVP) Market

29.1. Africa Large Volume Parenteral (LVP) Market Overview
29.2. Africa Large Volume Parenteral (LVP) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Large Volume Parenteral (LVP) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Large Volume Parenteral (LVP) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Large Volume Parenteral (LVP) Market Competitive Landscape And Company Profiles

30.1. Large Volume Parenteral (LVP) Market Competitive Landscape
30.2. Large Volume Parenteral (LVP) Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Fresenius Kabi AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Abbott Laboratories Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Becton Dickinson and Company
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Otsuka Holdings Co Ltd.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Large Volume Parenteral (LVP) Market Other Major And Innovative Companies

31.1. Baxter International Inc.
31.2. B Braun Melsungen AG
31.3. Grifols SA
31.4. Cipla Limited
31.5. ICU Medical Inc.
31.6. Biocon Limited
31.7. Sichuan Kelun Pharmaceutical Co. Ltd.
31.8. Alembic Pharmaceuticals Limited
31.9. Cadila Healthcare Ltd.
31.10. Gland Pharma Limited
31.11. Akums Drugs & Pharmaceuticals Ltd.
31.12. Beximco Pharmaceutical Ltd.
31.13. Nelson Laboratories LLC
31.14. Taj Pharmaceuticals Limited
31.15. Albert David Ltd.

32. Global Large Volume Parenteral (LVP) Market Competitive Benchmarking

33. Global Large Volume Parenteral (LVP) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Large Volume Parenteral (LVP) Market

35. Large Volume Parenteral (LVP) Market Future Outlook and Potential Analysis

35.1 Large Volume Parenteral (LVP) Market In 2028 - Countries Offering Most New Opportunities
35.2 Large Volume Parenteral (LVP) Market In 2028 - Segments Offering Most New Opportunities
35.3 Large Volume Parenteral (LVP) Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer